724 related articles for article (PubMed ID: 29936787)
21. Axillary lymph node dissection is not obligatory in breast cancer patients with biopsy-proven axillary lymph node metastasis.
Yoo TK; Kang BJ; Kim SH; Song BJ; Ahn J; Park WC; Chae BJ
Breast Cancer Res Treat; 2020 Jun; 181(2):403-409. PubMed ID: 32328848
[TBL] [Abstract][Full Text] [Related]
22. High rate of solitary sentinel node metastases identification by fluorescence-guided lymphatic imaging in breast cancer.
Hirche C; Mohr Z; Kneif S; Murawa D; Hünerbein M
J Surg Oncol; 2012 Feb; 105(2):162-6. PubMed ID: 21882198
[TBL] [Abstract][Full Text] [Related]
23. International multicenter tool to predict the risk of nonsentinel node metastases in breast cancer.
Meretoja TJ; Leidenius MH; Heikkilä PS; Boross G; Sejben I; Regitnig P; Luschin-Ebengreuth G; Žgajnar J; Perhavec A; Gazic B; Lázár G; Takács T; Vörös A; Saidan ZA; Nadeem RM; Castellano I; Sapino A; Bianchi S; Vezzosi V; Barranger E; Lousquy R; Arisio R; Foschini MP; Imoto S; Kamma H; Tvedskov TF; Kroman N; Jensen MB; Audisio RA; Cserni G
J Natl Cancer Inst; 2012 Dec; 104(24):1888-96. PubMed ID: 23117131
[TBL] [Abstract][Full Text] [Related]
24. The clinical meaning of intramammary lymph nodes.
Lee SK; Kim S; Choi MY; Kim J; Lee J; Jung SP; Choe JH; Kim JH; Kim JS; Kil WH; Lee JE; Nam SJ
Oncology; 2013; 84(1):1-5. PubMed ID: 23052128
[TBL] [Abstract][Full Text] [Related]
25. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer.
Inoue T; Nishi T; Nakano Y; Nishimae A; Sawai Y; Yamasaki M; Inaji H
Breast Cancer; 2016 Mar; 23(2):295-300. PubMed ID: 25348937
[TBL] [Abstract][Full Text] [Related]
26. Impact of axillary ultrasound (AUS) on axillary dissection in breast conserving surgery (BCS).
Reyna C; Kiluk JV; Frelick A; Khakpour N; Laronga C; Lee MC
J Surg Oncol; 2015 Jun; 111(7):813-8. PubMed ID: 25753101
[TBL] [Abstract][Full Text] [Related]
27. Factors that predict the burden of axillary disease in breast cancer patients with a positive sentinel node.
Beriwal S; Soran A; Kocer B; Wilson JW; Ahrendt GM; Johnson R
Am J Clin Oncol; 2008 Feb; 31(1):34-8. PubMed ID: 18376225
[TBL] [Abstract][Full Text] [Related]
28. Axillary tumour burden in women with a fine-needle aspiration/core biopsy-proven positive node on ultrasonography compared to women with a positive sentinel node.
Lloyd P; Theophilidou E; Newcombe RG; Pugh L; Goyal A
Br J Surg; 2017 Dec; 104(13):1811-1815. PubMed ID: 28991362
[TBL] [Abstract][Full Text] [Related]
29. Contrast-Enhanced Ultrasound Biopsy of Sentinel Lymph Nodes in Patients with Breast Cancer: Implications for Axillary Metastases and Conservation.
Cox K; Weeks J; Mills P; Chalmers R; Devalia H; Fish D; Sever A
Ann Surg Oncol; 2016 Jan; 23(1):58-64. PubMed ID: 25990967
[TBL] [Abstract][Full Text] [Related]
30. Predictive factors associated with axillary lymph node metastases in T1a and T1b breast carcinomas: analysis in more than 900 patients.
Rivadeneira DE; Simmons RM; Christos PJ; Hanna K; Daly JM; Osborne MP
J Am Coll Surg; 2000 Jul; 191(1):1-6; discussion 6-8. PubMed ID: 10898177
[TBL] [Abstract][Full Text] [Related]
31. A logistic regression model predicting high axillary tumour burden in early breast cancer patients.
Barco I; García Font M; García-Fernández A; Giménez N; Fraile M; Lain JM; Vallejo E; González S; Canales L; Deu J; Vidal MC; Rodríguez-Carballeira M; Pessarrodona A; Chabrera C
Clin Transl Oncol; 2017 Nov; 19(11):1393-1399. PubMed ID: 28808943
[TBL] [Abstract][Full Text] [Related]
32. A Dutch Prediction Tool to Assess the Risk of Additional Axillary Non-Sentinel Lymph Node Involvement in Sentinel Node-Positive Breast Cancer Patients.
van den Hoven I; van Klaveren D; Voogd AC; Vergouwe Y; Tjan-Heijnen V; Roumen RM
Clin Breast Cancer; 2016 Apr; 16(2):123-30. PubMed ID: 26602438
[TBL] [Abstract][Full Text] [Related]
33. Influence of tumor histology on preoperative staging accuracy of breast metastases to the axilla.
Hackney L; Williams S; Bajwa S; Morley-Davies AJ; Kirby RM; Britton I
Breast J; 2013; 19(1):49-55. PubMed ID: 23186153
[TBL] [Abstract][Full Text] [Related]
34. Characteristics of breast carcinoma cases with false-negative sentinel lymph nodes.
Wei S; Bleiweiss IJ; Nagi C; Jaffer S
Clin Breast Cancer; 2014 Aug; 14(4):280-4. PubMed ID: 24581736
[TBL] [Abstract][Full Text] [Related]
35. Does lymphovascular invasion predict regional nodal failure in breast cancer patients with zero to three positive lymph nodes treated with conserving surgery and radiotherapy? Implications for regional radiation.
Boutrus R; Abi-Raad R; Niemierko A; Brachtel EF; Rizk L; Kelada A; Taghian AG
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):793-8. PubMed ID: 20171799
[TBL] [Abstract][Full Text] [Related]
36. Sentinel lymph node biopsy alone has no adverse impact on the survival of patients with breast cancer.
Takei H; Suemasu K; Kurosumi M; Horii Y; Ninomiya J; Yoshida M; Hagiwara Y; Inoue K; Tabei T
Breast J; 2006; 12(5 Suppl 2):S157-64. PubMed ID: 16958996
[TBL] [Abstract][Full Text] [Related]
37. [Lobular invasive breast cancer prognostic factors: About 940 patients].
Jauffret C; Houvenaeghel G; Classe JM; Garbay JR; Giard S; Charitansky H; Cohen M; Bélichard C; Faure C; Darai É; Hudry D; Azuar P; Villet R; Gimbergues P; Tunon de Lara C; Martino M; Coutant C; Dravet F; Chauvet MP; Chéreau Ewald E; Penault-Llorca F; Goncalves A; Lambaudie É
Gynecol Obstet Fertil; 2015 Nov; 43(11):712-7. PubMed ID: 26482833
[TBL] [Abstract][Full Text] [Related]
38. Predictors of axillary lymph node metastases in patients with T1 breast carcinoma.
Barth A; Craig PH; Silverstein MJ
Cancer; 1997 May; 79(10):1918-22. PubMed ID: 9149018
[TBL] [Abstract][Full Text] [Related]
39. Patterns of axillary surgical care for breast cancer in the era of sentinel lymph node biopsy.
Rescigno J; Zampell JC; Axelrod D
Ann Surg Oncol; 2009 Mar; 16(3):687-96. PubMed ID: 19101768
[TBL] [Abstract][Full Text] [Related]
40. Triple assessment of sentinel lymph node metastasis in early breast cancer using preoperative CTLG, intraoperative fluorescence navigation and OSNA.
Mokhtar M; Tadokoro Y; Nakagawa M; Morimoto M; Takechi H; Kondo K; Tangoku A
Breast Cancer; 2016 Mar; 23(2):202-10. PubMed ID: 25069434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]